← All trials
NCT05023304
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 23, 2021
- Primary completion
- Jul 27, 2022
- Completion date
- Oct 1, 2022
- First posted
- Aug 26, 2021
- Last posted
- Aug 26, 2021
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vance Thompson VisionLead sponsor
- Ocular Therapeutix, Inc.Collaborator
- Vance Thompson VisionSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.